# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015508
Filing Date
2022-04-22
Accepted
2022-04-22 08:00:31
Documents
6
Period of Report
2022-06-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20002213x1_def14a.htm | DEF 14A | 1100204
2 |  | logo_pmvpharma.jpg | GRAPHIC | 55635
3 |  | ny20002213x1_pc1.jpg | GRAPHIC | 606323
4 |  | ny20002213x1_pc2.jpg | GRAPHIC | 419481
5 |  | sig_davidhmack.jpg | GRAPHIC | 15618
6 |  | sig_robertticktin.jpg | GRAPHIC | 17857
| Complete submission text file | 0001140361-22-015508.txt |  | 2635475

Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39539 | Film No.: 22843418
SIC: 2834 Pharmaceutical Preparations